AARTI DRUGS
Back to Balance Sheet
|
AARTI DRUGS Last 5 Year Total Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹837 Cr | ₹796 Cr | ₹949 Cr | ₹940 Cr | ₹595 Cr |
What is the latest Total Current Liabilities ratio of AARTI DRUGS ?
| Year | Total Current Liabilities |
|---|---|
| Mar2025 | ₹837 Cr |
| Mar2024 | ₹796 Cr |
| Mar2023 | ₹949 Cr |
| Mar2022 | ₹940 Cr |
| Mar2021 | ₹595 Cr |
How is Total Current Liabilities of AARTI DRUGS Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹837 Cr | 5.21 | |
| Mar2024 | ₹796 Cr | -16.21 | |
| Mar2023 | ₹949 Cr | 1.00 | |
| Mar2022 | ₹940 Cr | 57.90 | |
| Mar2021 | ₹595 Cr | - | |
Compare Total Current Liabilities of peers of AARTI DRUGS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| AARTI DRUGS | ₹3,516.0 Cr | -4.9% | -1.3% | -14% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹415,073.0 Cr | -0% | -3.2% | -5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹175,657.0 Cr | 4% | 5.2% | 11.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹134,121.0 Cr | 3.6% | 7% | 22% | Stock Analytics | |
| CIPLA | ₹118,431.0 Cr | -3.5% | -1.5% | -2.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,944.0 Cr | -3.2% | -3.3% | -10.6% | Stock Analytics | |
AARTI DRUGS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| AARTI DRUGS | -4.9% |
-1.3% |
-14% |
| SENSEX | -2.6% |
-1.3% |
7.2% |
You may also like the below Video Courses